| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.003 |